EUVIMEDEUVIMED entdecken
Open Access

Pediatric Ewing's Sarcoma and Permanent Chemotherapy‐Induced Alopecia: A Case–Control Study

Madeline Lillich iD, Stuart Gold, Diana McShane

Pediatric Dermatology · 2025

DOI: 10.1111/pde.15907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Madeline Lillich und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Alopecia, Antineoplastic Agents, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, National Center for Advancing Translational Sciences (NCATS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Permanent chemotherapy‐induced alopecia (PCIA), defined as the persistence of hair loss for > 6 months following chemotherapy cessation, is a rare pediatric diagnosis. A retrospective chart review was conducted to characterize cases of PCIA not previously reported in pediatric Ewing's sarcoma (ES) patients after completion of therapeutic chemotherapy, comparing demographic factors, cumulative chemotherapy dosing, family history of hair loss, and treatment methodologies with a control group. Of 12 patients with an history of pediatric ES, three were diagnosed with PCIA. Our findings suggest that PCIA can occur after treatment for ES in the pediatric population and that treatments, including topical and oral minoxidil, can be beneficial but may not result in complete hair regrowth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingAlopeciaAntineoplastic AgentsBone NeoplasmsHumansChildFemaleRetrospective StudiesMaleCase-Control StudiesAdolescentChild, PreschoolMinoxidil

Stichwörter der Autor:innen

Ewing's sarcomaalopeciachemotherapydrug toxicitysurvivors of childhood cancer

Substanzen

Antineoplastic AgentsMinoxidil

Autor:innen und Institutionen

  • School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Department of Pediatrics, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina, USA.

ORCID-Profile: Madeline Lillich

Förderung

  • NCATS NIH HHS
  • NIH HHS
  • National Center for Advancing Translational Sciences (NCATS)
  • National Institutes of Health

Zitieren

APA

Lillich, M., Gold, S., & McShane, D. (2025). Pediatric Ewing's Sarcoma and Permanent Chemotherapy‐Induced Alopecia: A Case–Control Study. Pediatric Dermatology. https://doi.org/10.1111/pde.15907

Vancouver

Lillich M, Gold S, McShane D. Pediatric Ewing's Sarcoma and Permanent Chemotherapy‐Induced Alopecia: A Case–Control Study. Pediatric Dermatology. 2025. doi:10.1111/pde.15907

BibTeX
@article{Lillich2025,
  author = {Lillich, Madeline and Gold, Stuart and McShane, Diana},
  title = {Pediatric Ewing's Sarcoma and Permanent Chemotherapy‐Induced Alopecia: A Case–Control Study},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.15907}
}
Kostenlos starten →